Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Body fluid or exudate or transudate other than snake venom,...
Patent
1993-04-02
1994-01-11
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Body fluid or exudate or transudate other than snake venom,...
424559, 424573, A61K 4500, A61K 3512
Patent
active
052779173
ABSTRACT:
Herein described is an ovarian cancer activating factor that has been isolated from ovarian cancer ascites fluid. The factor may be utilized in its isolated form in a screening program aimed at identifying inhibitors of factor-mediated ovarian cancer activation, or as a growth supplement useful for culturing ovarian and other cancer cell lines.
REFERENCES:
Bligh et al., "A rapid method of total lipid extraction and purification" Can. J. Biochem. Physiol., 1959, 37:911.
Buick et al., "Comparative properties of five human ovarian adenocarcinoma cell lines" Cancer Research, 1985, 45:3668.
Mills et al., "A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action" Cancer Research, 1988, 48:1066.
Mills et al., "Role of growth factors: their receptors and signalling pathways in the diagnosis, prognosis, follow-up and therapy of ovarian cancer" Diagn. Oncol., 1992, 2:39.
Mills et al., "Regulation of growth of human ovarian cancer cells". Ovarian Cancer 2: Biology Diagnosis and Management (Eds. Sharp, et al.), Chapman and Hall, London, 1992, pp. 127-143.
Mills et al., "Regulatory mechanisms in ascitic fluid" Ovarian Cancer: Biologic and therapeutic challenges. (Eds. F. Sharp et al.) Chapman and Hall Medical, London, 1989, pp. 55-62.
Mills et al., "Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian cancer cells" J. Clin. Invest., 1990, 86:851.
Schact "Extraction and purification of polyphosphoinositides" Methods Enzymol., 1981, 72:626.
Goodbody Anne E.
Xu Yan
Allelix Biopharmaceuticals Inc.
Robinson Douglas W.
Witz Jean C.
LandOfFree
Ovarian cancer ascites factor, in isolated form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ovarian cancer ascites factor, in isolated form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ovarian cancer ascites factor, in isolated form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1629597